Understanding DEA and State Positions on Prescribing Controlled Medication During the COVID-19 Public Health Emergency
Paradigm Labs is doing its part to support healthcare providers and their patients during the COVID-19 Public Health Emergency (COVID-19 PHE). To this end, Paradigm Labs has developed a drug testing platform that allows providers and patients to engage in oral fluid drug testing facilitated by a telemedicine “visit.”
The U.S. Drug Administration has activated the public health emergency provision of the Ryan Haight Act, thereby allowing DEA registrants to prescribe controlled substances without an in-person medical exam of the patient for the duration of COVID-19 PHE and subject to the additional requirements set forth below. If you have questions about prescribing controlled substances via telemedicine in your state, contact your licensing board and/or legal counsel.
Link to March 2020 Arizona State Brief.
Link to March 2020 Georgia State Brief.
